Arvinas Accounts Payable vs Current Deferred Revenue Analysis

ARVN Stock

USD 26.72 0.74 2.85%

Arvinas financial indicator trend analysis is way more than just evaluating Arvinas prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arvinas is a good investment. Please check the relationship between Arvinas Accounts Payable and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

Accounts Payable vs Current Deferred Revenue

Accounts Payable vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arvinas Accounts Payable account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between Arvinas' Accounts Payable and Current Deferred Revenue is 0.78. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Arvinas, assuming nothing else is changed. The correlation between historical values of Arvinas' Accounts Payable and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Arvinas are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Accounts Payable i.e., Arvinas' Accounts Payable and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.78

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Arvinas obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Arvinas are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Arvinas' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arvinas current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.At this time, Arvinas' Selling General Administrative is very stable compared to the past year. As of the 1st of December 2024, Enterprise Value is likely to grow to about 2.6 B, while Tax Provision is likely to drop about 5.7 M.

	2021	2022	2023	2024 (projected)
Interest Income	1.9M	12.2M	32.3M	33.9M
Net Interest Income	1.8M	12.2M	32.3M	33.9M

Interest Income Net Interest Income

Arvinas fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity
Total Assets		0.86	0.77	0.96	0.96	0.91	0.96	0.93	0.95	-0.53	-0.85	0.87	0.52	0.99	0.8	0.42	0.38	1.0	0.48	-0.75	0.95	0.96	0.44	0.95	0.93	0.9
Short Long Term Debt Total	0.86		0.67	0.78	0.89	0.71	0.9	0.97	0.77	-0.5	-0.76	0.65	0.5	0.91	0.59	0.48	0.73	0.85	0.35	-0.91	0.85	0.8	0.74	0.74	0.85	0.83
Other Current Liab	0.77	0.67		0.76	0.78	0.81	0.75	0.77	0.7	-0.72	-0.96	0.5	0.63	0.78	0.83	0.36	0.37	0.77	0.19	-0.68	0.83	0.66	0.44	0.66	0.66	0.95
Total Current Liabilities	0.96	0.78	0.76		0.86	0.92	0.85	0.86	0.99	-0.35	-0.84	0.77	0.34	0.96	0.89	0.57	0.22	0.96	0.46	-0.64	0.91	0.97	0.28	0.98	0.95	0.85
Total Stockholder Equity	0.96	0.89	0.78	0.86		0.81	1.0	0.96	0.83	-0.71	-0.83	0.83	0.71	0.95	0.67	0.31	0.53	0.96	0.38	-0.82	0.93	0.85	0.58	0.84	0.85	0.9
Other Liab	0.91	0.71	0.81	0.92	0.81		0.79	0.79	0.92	-0.38	-0.9	0.82	0.3	0.89	0.95	0.35	0.21	0.91	0.55	-0.63	0.85	0.93	0.28	0.94	0.87	0.91
Net Tangible Assets	0.96	0.9	0.75	0.85	1.0	0.79		0.96	0.83	-0.69	-0.81	0.82	0.7	0.95	0.64	0.32	0.57	0.96	0.37	-0.84	0.92	0.85	0.62	0.83	0.85	0.89
Property Plant And Equipment Net	0.93	0.97	0.77	0.86	0.96	0.79	0.96		0.84	-0.62	-0.83	0.72	0.61	0.97	0.67	0.47	0.61	0.93	0.38	-0.87	0.94	0.85	0.65	0.82	0.88	0.89
Current Deferred Revenue	0.95	0.77	0.7	0.99	0.83	0.92	0.83	0.84		-0.28	-0.8	0.78	0.28	0.95	0.88	0.59	0.19	0.95	0.5	-0.61	0.89	0.98	0.24	0.98	0.97	0.81
Net Debt	-0.53	-0.5	-0.72	-0.35	-0.71	-0.38	-0.69	-0.62	-0.28		0.6	-0.38	-0.98	-0.5	-0.28	0.03	-0.49	-0.53	-0.03	0.56	-0.59	-0.26	-0.54	-0.28	-0.31	-0.67
Retained Earnings	-0.85	-0.76	-0.96	-0.84	-0.83	-0.9	-0.81	-0.83	-0.8	0.6		-0.64	-0.52	-0.86	-0.88	-0.34	-0.44	-0.85	-0.31	0.78	-0.86	-0.79	-0.52	-0.78	-0.74	-0.98
Accounts Payable	0.87	0.65	0.5	0.77	0.83	0.82	0.82	0.72	0.78	-0.38	-0.64		0.38	0.81	0.62	-0.01	0.26	0.87	0.57	-0.59	0.75	0.85	0.31	0.86	0.74	0.71
Cash	0.52	0.5	0.63	0.34	0.71	0.3	0.7	0.61	0.28	-0.98	-0.52	0.38		0.5	0.19	-0.01	0.48	0.53	0.0	-0.53	0.59	0.25	0.53	0.27	0.3	0.6
Non Current Assets Total	0.99	0.91	0.78	0.96	0.95	0.89	0.95	0.97	0.95	-0.5	-0.86	0.81	0.5		0.8	0.5	0.44	0.99	0.45	-0.79	0.96	0.95	0.49	0.93	0.95	0.9
Non Currrent Assets Other	0.8	0.59	0.83	0.89	0.67	0.95	0.64	0.67	0.88	-0.28	-0.88	0.62	0.19	0.8		0.49	0.07	0.8	0.4	-0.52	0.77	0.85	0.14	0.86	0.81	0.85
Other Assets	0.42	0.48	0.36	0.57	0.31	0.35	0.32	0.47	0.59	0.03	-0.34	-0.01	-0.01	0.5	0.49		0.07	0.42	0.05	-0.27	0.45	0.48	0.06	0.45	0.66	0.32
Long Term Debt	0.38	0.73	0.37	0.22	0.53	0.21	0.57	0.61	0.19	-0.49	-0.44	0.26	0.48	0.44	0.07	0.07		0.38	0.03	-0.88	0.35	0.27	0.99	0.18	0.31	0.5
Cash And Short Term Investments	1.0	0.85	0.77	0.96	0.96	0.91	0.96	0.93	0.95	-0.53	-0.85	0.87	0.53	0.99	0.8	0.42	0.38		0.47	-0.75	0.95	0.95	0.44	0.95	0.93	0.9
Net Receivables	0.48	0.35	0.19	0.46	0.38	0.55	0.37	0.38	0.5	-0.03	-0.31	0.57	0.0	0.45	0.4	0.05	0.03	0.47		-0.18	0.39	0.53	0.03	0.59	0.48	0.36
Common Stock Total Equity	-0.75	-0.91	-0.68	-0.64	-0.82	-0.63	-0.84	-0.87	-0.61	0.56	0.78	-0.59	-0.53	-0.79	-0.52	-0.27	-0.88	-0.75	-0.18		-0.7	-0.67	-0.91	-0.6	-0.67	-0.82
Common Stock Shares Outstanding	0.95	0.85	0.83	0.91	0.93	0.85	0.92	0.94	0.89	-0.59	-0.86	0.75	0.59	0.96	0.77	0.45	0.35	0.95	0.39	-0.7		0.87	0.41	0.87	0.86	0.89
Short Term Investments	0.96	0.8	0.66	0.97	0.85	0.93	0.85	0.85	0.98	-0.26	-0.79	0.85	0.25	0.95	0.85	0.48	0.27	0.95	0.53	-0.67	0.87		0.31	0.99	0.96	0.81
Long Term Debt Total	0.44	0.74	0.44	0.28	0.58	0.28	0.62	0.65	0.24	-0.54	-0.52	0.31	0.53	0.49	0.14	0.06	0.99	0.44	0.03	-0.91	0.41	0.31		0.24	0.33	0.57
Non Current Liabilities Total	0.95	0.74	0.66	0.98	0.84	0.94	0.83	0.82	0.98	-0.28	-0.78	0.86	0.27	0.93	0.86	0.45	0.18	0.95	0.59	-0.6	0.87	0.99	0.24		0.94	0.81
Other Current Assets	0.93	0.85	0.66	0.95	0.85	0.87	0.85	0.88	0.97	-0.31	-0.74	0.74	0.3	0.95	0.81	0.66	0.31	0.93	0.48	-0.67	0.86	0.96	0.33	0.94		0.79
Other Stockholder Equity	0.9	0.83	0.95	0.85	0.9	0.91	0.89	0.89	0.81	-0.67	-0.98	0.71	0.6	0.9	0.85	0.32	0.5	0.9	0.36	-0.82	0.89	0.81	0.57	0.81	0.79

Click cells to compare fundamentals

Arvinas Account Relationship Matchups

Arvinas fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	301.6M	717.4M	1.6B	1.3B	1.3B	753.2M
Short Long Term Debt Total	4.4M	4.0M	5M	5.5M	3.2M	3.4M
Other Current Liab	7.6M	41.0M	22M	56.9M	73.7M	77.4M
Total Current Liabilities	32.8M	49.1M	261.7M	295.1M	257.1M	130.2M
Total Stockholder Equity	226.7M	642.3M	781.7M	564.9M	660M	417.5M
Other Liab	38.4M	22.9M	534.3M	405.1M	465.9M	489.2M
Net Tangible Assets	226.7M	642.3M	781.7M	564.9M	649.6M	354.8M
Property Plant And Equipment Net	10.7M	14.3M	16.6M	17.8M	14M	10.8M
Current Deferred Revenue	20.0M	22.2M	206.2M	218.6M	163M	91.6M
Net Debt	(4.8M)	(584.3M)	(103.3M)	(75.8M)	(308.5M)	(293.1M)
Retained Earnings	(372.6M)	(491.9M)	(682.9M)	(965.4M)	(1.3B)	(1.3B)
Accounts Payable	4.6M	7.1M	31.3M	5.7M	17.8M	9.8M
Cash	9.2M	588.4M	108.3M	81.3M	311.7M	156.5M
Non Current Assets Total	10.8M	14.3M	29.1M	28.6M	24.4M	15.5M
Non Currrent Assets Other	(1.3M)	(2.4M)	7.5M	10.8M	10.4M	10.9M
Other Assets	26.8K	28.8K	100K	10.8M	1.0	0.95
Cash And Short Term Investments	280.9M	688.5M	1.5B	1.2B	1.3B	715.1M
Net Receivables	6.3M	1M	25.7M	8M	7.2M	11.1M
Common Stock Total Equity	31.2K	38.5K	48.5K	100K	90K	85.5K
Common Stock Shares Outstanding	32.9M	39.5M	50M	53.2M	55.5M	38.4M
Short Term Investments	271.7M	100.2M	1.4B	1.1B	949.3M	558.6M
Liabilities And Stockholders Equity	301.6M	717.4M	1.6B	1.3B	1.3B	753.2M
Non Current Liabilities Total	42.1M	26.0M	538.2M	408.8M	387.5M	205.6M
Other Current Assets	3.7M	6.1M	24.2M	26.9M	12M	10.5M
Other Stockholder Equity	599.1M	1.1B	1.5B	1.5B	2.0B	2.1B
Total Liab	75.0M	75.1M	799.9M	703.9M	644.6M	335.7M
Property Plant And Equipment Gross	10.7M	14.3M	16.6M	17.8M	35.1M	36.9M
Total Current Assets	290.9M	703.1M	1.6B	1.2B	1.3B	737.7M
Accumulated Other Comprehensive Income	107.6K	560.8K	(4.6M)	(19.2M)	(3.1M)	(3.3M)
Non Current Liabilities Other	40.1M	24.0M	537.2M	407.8M	469.0M	492.4M
Short Term Debt	673.9K	1M	2.2M	3.6M	1.9M	1.4M
Common Stock	31.2K	38.5K	48.5K	100K	90K	85.5K
Property Plant Equipment	10.7M	12.3M	16.6M	13.4M	15.4M	9.2M
Net Invested Capital	228.7M	644.3M	782.7M	565.9M	660.8M	465.2M
Net Working Capital	258.1M	654.0M	1.3B	945.1M	1.0B	690.1M
Retained Earnings Total Equity	(372.6M)	(491.9M)	(682.9M)	(965.4M)	(868.9M)	(912.3M)
Capital Surpluse	599.1M	1.1B	1.5B	1.5B	1.8B	1.1B

Pair Trading with Arvinas

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arvinas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will appreciate offsetting losses from the drop in the long position's value.

Moving against Arvinas Stock

0.35

AVAL

Grupo Aval

Pair Corr

The ability to find closely correlated positions to Arvinas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arvinas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arvinas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arvinas to buy it.

The correlation of Arvinas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Arvinas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock:

How To Invest In Arvinas

Details

Is Arvinas Stock a good investment?

Details

What is Arvinas' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.79)

Revenue Per Share

2.327

Quarterly Revenue Growth

1.96

Return On Assets

(0.20)

Return On Equity

(0.59)

The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Arvinas Accounts Payable vs Current Deferred Revenue Analysis

Accounts Payable vs Current Deferred Revenue

Accounts Payable vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Accounts Payable

Current Deferred Revenue

Arvinas fundamental ratios Correlations

Arvinas Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Arvinas fundamental ratios Accounts

Pair Trading with Arvinas

Moving against Arvinas Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 0.99	Total Assets
Current Deferred Revenue	+ 0.99	Total Current Liabilities
Cash And Short Term Investments	+ 0.99	Non Current Assets Total
Long Term Debt Total	+ 0.99	Long Term Debt

Other Stockholder Equity	- 0.98	Retained Earnings
Cash	- 0.98	Net Debt
Retained Earnings	- 0.96	Other Current Liab
Long Term Debt Total	- 0.91	Common Stock Total Equity
Common Stock Total Equity	- 0.91	Short Long Term Debt Total
Retained Earnings	- 0.9	Other Liab